EMvision Selling And Marketing Expenses vs Income Before Tax Analysis

EMV Stock

1.88 0.05 2.59%

EMvision Medical financial indicator trend analysis is much more than just examining EMvision Medical Devices latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether EMvision Medical Devices is a good investment. Please check the relationship between EMvision Medical Selling And Marketing Expenses and its Income Before Tax accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in EMvision Medical Devices. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Selling And Marketing Expenses vs Income Before Tax

Selling And Marketing Expenses vs Income Before Tax Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of EMvision Medical Devices Selling And Marketing Expenses account and Income Before Tax. At this time, the significance of the direction appears to have pay attention.

The correlation between EMvision Medical's Selling And Marketing Expenses and Income Before Tax is -0.8. Overlapping area represents the amount of variation of Selling And Marketing Expenses that can explain the historical movement of Income Before Tax in the same time period over historical financial statements of EMvision Medical Devices, assuming nothing else is changed. The correlation between historical values of EMvision Medical's Selling And Marketing Expenses and Income Before Tax is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Selling And Marketing Expenses of EMvision Medical Devices are associated (or correlated) with its Income Before Tax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Income Before Tax has no effect on the direction of Selling And Marketing Expenses i.e., EMvision Medical's Selling And Marketing Expenses and Income Before Tax go up and down completely randomly.

Correlation Coefficient

-0.8

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Selling And Marketing Expenses

Income Before Tax

Income Before Tax which can also be referred as pre-tax income is reported on EMvision Medical income statement and is an important metric when analyzing EMvision Medical Devices profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.

Most indicators from EMvision Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into EMvision Medical Devices current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in EMvision Medical Devices. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

At this time, EMvision Medical's Tax Provision is comparatively stable compared to the past year. Issuance Of Capital Stock is likely to gain to about 16 M in 2024, whereas Selling General Administrative is likely to drop slightly above 1.5 M in 2024.

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	243.3K	342.0K	410.6K	390.1K
Interest Income	15.6K	35.3K	341.2K	358.3K

Depreciation And Amortization Interest Income

EMvision Medical fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Intangible Assets	Common Stock	Common Stock Total Equity	Non Current Liabilities Total	Net Invested Capital	Capital Stock	Net Working Capital	Short Long Term Debt Total
Total Assets		0.97	0.61	0.98	0.67	-0.98	-0.89	-0.22	1.0	0.82	0.55	1.0	0.89	0.8	0.86	0.75	0.86	1.0	0.82	0.88	0.78	0.86	0.97	0.89	0.94	0.76
Other Current Liab	0.97		0.58	0.95	0.5	-0.93	-0.82	-0.18	0.96	0.81	0.66	0.96	0.92	0.75	0.78	0.65	0.86	0.97	0.88	0.8	0.67	0.95	0.98	0.85	0.96	0.76
Total Current Liabilities	0.61	0.58		0.46	0.36	-0.57	-0.76	0.25	0.63	0.7	0.0	0.63	0.82	0.73	0.66	0.65	0.9	0.61	0.43	0.72	0.62	0.4	0.48	0.73	0.37	0.95
Total Stockholder Equity	0.98	0.95	0.46		0.71	-0.99	-0.84	-0.3	0.98	0.78	0.59	0.98	0.79	0.74	0.84	0.72	0.75	0.98	0.82	0.84	0.76	0.85	0.97	0.85	0.97	0.64
Net Tangible Assets	0.67	0.5	0.36	0.71		-0.77	-0.78	-0.41	0.72	0.58	-0.05	0.72	0.37	0.66	0.79	0.84	0.44	0.68	0.3	0.78	0.84	0.25	0.55	0.7	0.54	0.38
Net Debt	-0.98	-0.93	-0.57	-0.99	-0.77		0.89	0.24	-0.99	-0.81	-0.5	-0.99	-0.82	-0.79	-0.89	-0.79	-0.79	-0.99	-0.79	-0.9	-0.83	-0.78	-0.94	-0.9	-0.92	-0.71
Retained Earnings	-0.89	-0.82	-0.76	-0.84	-0.78	0.89		0.28	-0.91	-0.9	-0.13	-0.91	-0.81	-0.93	-0.92	-0.94	-0.87	-0.89	-0.6	-0.95	-0.89	-0.64	-0.79	-0.94	-0.73	-0.83
Accounts Payable	-0.22	-0.18	0.25	-0.3	-0.41	0.24	0.28		-0.21	-0.22	0.09	-0.21	0.06	-0.39	-0.25	-0.4	0.04	-0.21	-0.01	-0.18	-0.23	-0.17	-0.27	-0.22	-0.32	0.16
Cash	1.0	0.96	0.63	0.98	0.72	-0.99	-0.91	-0.21		0.82	0.51	1.0	0.88	0.81	0.87	0.78	0.86	1.0	0.78	0.89	0.81	0.82	0.95	0.9	0.92	0.76
Non Current Assets Total	0.82	0.81	0.7	0.78	0.58	-0.81	-0.9	-0.22	0.82		0.22	0.82	0.76	0.89	0.93	0.89	0.8	0.81	0.78	0.95	0.82	0.71	0.76	0.97	0.71	0.85
Non Currrent Assets Other	0.55	0.66	0.0	0.59	-0.05	-0.5	-0.13	0.09	0.51	0.22		0.51	0.52	0.09	0.19	-0.08	0.33	0.56	0.76	0.2	0.07	0.77	0.7	0.27	0.74	0.23
Cash And Short Term Investments	1.0	0.96	0.63	0.98	0.72	-0.99	-0.91	-0.21	1.0	0.82	0.51		0.88	0.81	0.87	0.78	0.86	1.0	0.78	0.89	0.81	0.82	0.95	0.9	0.92	0.76
Net Receivables	0.89	0.92	0.82	0.79	0.37	-0.82	-0.81	0.06	0.88	0.76	0.52	0.88		0.75	0.71	0.6	0.98	0.89	0.76	0.76	0.61	0.83	0.86	0.8	0.79	0.91
Common Stock Shares Outstanding	0.8	0.75	0.73	0.74	0.66	-0.79	-0.93	-0.39	0.81	0.89	0.09	0.81	0.75		0.84	0.9	0.81	0.79	0.59	0.9	0.88	0.58	0.73	0.93	0.67	0.81
Other Current Assets	0.86	0.78	0.66	0.84	0.79	-0.89	-0.92	-0.25	0.87	0.93	0.19	0.87	0.71	0.84		0.94	0.75	0.85	0.71	0.97	0.85	0.62	0.77	0.96	0.73	0.77
Other Stockholder Equity	0.75	0.65	0.65	0.72	0.84	-0.79	-0.94	-0.4	0.78	0.89	-0.08	0.78	0.6	0.9	0.94		0.69	0.75	0.49	0.94	0.9	0.45	0.63	0.91	0.58	0.71
Total Liab	0.86	0.86	0.9	0.75	0.44	-0.79	-0.87	0.04	0.86	0.8	0.33	0.86	0.98	0.81	0.75	0.69		0.85	0.66	0.8	0.67	0.73	0.79	0.83	0.7	0.95
Total Current Assets	1.0	0.97	0.61	0.98	0.68	-0.99	-0.89	-0.21	1.0	0.81	0.56	1.0	0.89	0.79	0.85	0.75	0.85		0.81	0.87	0.78	0.86	0.97	0.89	0.94	0.76
Intangible Assets	0.82	0.88	0.43	0.82	0.3	-0.79	-0.6	-0.01	0.78	0.78	0.76	0.78	0.76	0.59	0.71	0.49	0.66	0.81		0.72	0.56	0.89	0.87	0.78	0.87	0.68
Common Stock	0.88	0.8	0.72	0.84	0.78	-0.9	-0.95	-0.18	0.89	0.95	0.2	0.89	0.76	0.9	0.97	0.94	0.8	0.87	0.72		0.94	0.62	0.78	0.99	0.73	0.83
Common Stock Total Equity	0.78	0.67	0.62	0.76	0.84	-0.83	-0.89	-0.23	0.81	0.82	0.07	0.81	0.61	0.88	0.85	0.9	0.67	0.78	0.56	0.94		0.44	0.66	0.9	0.62	0.69
Non Current Liabilities Total	0.86	0.95	0.4	0.85	0.25	-0.78	-0.64	-0.17	0.82	0.71	0.77	0.82	0.83	0.58	0.62	0.45	0.73	0.86	0.89	0.62	0.44		0.93	0.69	0.92	0.64
Net Invested Capital	0.97	0.98	0.48	0.97	0.55	-0.94	-0.79	-0.27	0.95	0.76	0.7	0.95	0.86	0.73	0.77	0.63	0.79	0.97	0.87	0.78	0.66	0.93		0.83	0.99	0.68
Capital Stock	0.89	0.85	0.73	0.85	0.7	-0.9	-0.94	-0.22	0.9	0.97	0.27	0.9	0.8	0.93	0.96	0.91	0.83	0.89	0.78	0.99	0.9	0.69	0.83		0.78	0.86
Net Working Capital	0.94	0.96	0.37	0.97	0.54	-0.92	-0.73	-0.32	0.92	0.71	0.74	0.92	0.79	0.67	0.73	0.58	0.7	0.94	0.87	0.73	0.62	0.92	0.99	0.78		0.58
Short Long Term Debt Total	0.76	0.76	0.95	0.64	0.38	-0.71	-0.83	0.16	0.76	0.85	0.23	0.76	0.91	0.81	0.77	0.71	0.95	0.76	0.68	0.83	0.69	0.64	0.68	0.86	0.58

Click cells to compare fundamentals

EMvision Medical Account Relationship Matchups

EMvision Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	6.0M	10.8M	8.5M	11.5M	24.0M	25.2M
Other Current Liab	170.1K	313.1K	478.9K	682.7K	2.1M	2.2M
Total Current Liabilities	489.7K	676.2K	854.0K	6.0M	3.4M	1.9M
Total Stockholder Equity	5.5M	10.1M	7.1M	5.1M	18.5M	19.4M
Net Tangible Assets	5.0M	9.6M	6.6M	4.6M	5.3M	5.6M
Net Debt	(5.4M)	(9.5M)	(6.1M)	(6.9M)	(15.7M)	(14.9M)
Retained Earnings	(7.3M)	(15.7M)	(21.8M)	(25.7M)	(26.5M)	(25.2M)
Accounts Payable	319.6K	193.7K	178.2K	330.7K	293.5K	221.1K
Cash	5.4M	9.7M	6.8M	10.0M	18.6M	19.5M
Non Current Assets Total	480.0K	798.7K	1.4M	1.3M	2.1M	1.1M
Cash And Short Term Investments	5.4M	9.7M	6.8M	10.0M	18.6M	19.5M
Net Receivables	81.3K	117.4K	69.9K	2.9M	3.4M	3.5M
Common Stock Shares Outstanding	61.4M	70.1M	75.2M	77.7M	80.4M	73.8M
Liabilities And Stockholders Equity	6.0M	10.8M	8.5M	11.5M	24.0M	25.2M
Inventory	(38.0K)	51.1K	130.1K	5.9K	6.8K	6.5K
Other Current Assets	43.3K	285.8K	269.8K	265.2K	463.5K	236.5K
Other Stockholder Equity	840.6K	4.3M	5.7M	4.5M	5.2M	2.9M
Total Liab	489.7K	720.0K	1.4M	6.4M	5.5M	5.7M
Total Current Assets	5.5M	10.0M	7.1M	10.2M	21.9M	23.0M
Common Stock	12.0M	21.4M	23.2M	26.2M	41.6M	21.1M
Non Current Liabilities Total	43.8K	43.8K	571.6K	365.9K	2.0M	2.1M
Net Invested Capital	5.5M	10.1M	7.1M	7.6M	21.1M	22.2M
Accumulated Other Comprehensive Income	840.6K	4.3M	5.7M	4.5M	3.5M	3.6M
Capital Stock	12.0M	21.4M	23.2M	26.2M	41.6M	24.2M
Net Working Capital	5.0M	9.3M	6.2M	4.2M	18.5M	19.4M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for EMvision Stock Analysis

When running EMvision Medical's price analysis, check to measure EMvision Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EMvision Medical is operating at the current time. Most of EMvision Medical's value examination focuses on studying past and present price action to predict the probability of EMvision Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EMvision Medical's price. Additionally, you may evaluate how the addition of EMvision Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC